Thomas J. Appio
Net Worth

Last updated:

What is Thomas J. Appio net worth?

The estimated net worth of Mr. Thomas J. Appio is at least $16,130,658 as of 10 May 2022. He owns shares worth $1,010,658 as insider and has received compensation worth at least $15,120,000 in Bausch Health Companies Inc..

What is the salary of Thomas J. Appio?

Mr. Thomas J. Appio salary is $2,160,000 per year as Pres & Co-Head Bausch + Lomb/International in Bausch Health Companies Inc..

How old is Thomas J. Appio?

Mr. Thomas J. Appio is 63 years old, born in 1962.

What stocks does Thomas J. Appio currently own?

As insider, Mr. Thomas J. Appio owns shares in one company:

Company Title Shares Price per share Total value
Bausch Health Companies Inc. (BHC) Pres & Co-Head Bausch + Lomb/International 128,922 $7.84 $1,010,658

What does Bausch Health Companies Inc. do?

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

BHC logo
BHC
Bausch Health Companies Inc.
$7.84

Thomas J. Appio insider trading

Bausch Health Companies Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Share Units 19,575 $9.4 $184,005
Option
Common Shares, No Par Value 19,575 N/A N/A
Option
Common Shares, No Par Value 12,447 N/A N/A
Option
Common Shares, No Par Value 24,292 N/A N/A
Option
Restricted Share Units 24,292 $24.35 $591,510
Option
Restricted Share Units 9,161 N/A N/A
Option
Common Shares, No Par Value 9,161 N/A N/A
Option
Restricted Share Units 3,932 N/A N/A
Option
Common Stock, No Par Value 3,932 N/A N/A
Purchase
Common Stock, No Par Value 25,440 N/A N/A

Bausch Health Companies key executives

Bausch Health Companies Inc. executives and other stock owners filed with the SEC: